Evgen Pharma Share Discussion Threads

[nico115] 27/3/2021 13:53

And if the directors were onlyLookingFor 3 to 5m why did they raise 10m ? Maybe they aren't confident of decent trial results ?I bought a chunk at 8p but now seriouslyConsidering dumping them Director buys or lack of them worries me

[the millipede] 27/3/2021 13:29

The former CEO had quite a lot of shares, but he might have sold.

Anyone have any idea why he left? (Beyond what was written in the RNS.)

[on target] 27/3/2021 13:05

The directors' very modest holdings and their tiny top-ups in the recent placing are annoying, and I'd very much like them to put some decent money in. However, you can't ignore the fact that EVG is well backed by quality institutional investors, especially in the recent placing. It gives plenty of reassurance that there isn't 'something up' that these guys saw fit to invest millions earlier this month:



Major shareholder
Number of shares
Percentage holding


AXA Framlington
23,848,884
8.7%


Octopus Investments
21,875,000
8.0%


SPARK Impact
16,186,446
5.9%


Seneca Investment Managers
14,932,071
5.4%


Chelverton Asset Management
12,500,000
4.5%


RAB Capital
8,750,000
3.2%


Newlands Capital
8,314,815
3.0%

[nico115] 27/3/2021 11:20

No money munch Octopus bought a chunk of Verditek at 8p and have halved their money I rather back directors Oh 3k shares bought This is poo

[moneymunch] 27/3/2021 09:57

Maybe he should be voicing his concerns to the UK's leading and most powerful VC group, who have just invested £1.75m in Evgen, along with Chelverton Assest Management's £1m and RAB Capiatl's £700k as well as AXA inreasing their holding by another £1m plus and Seneca by £750k, a supreme show of confidence in Evgen's prospects and potential going forward, fully funded until mid 2023 with multiple shots on multiple targets. Gla Holders....news on Prof Chalmers preliminary efficacy assessment from SFX-01's Covid/ARDS patient trials coming soon, positive data will be very well received. ;-)



March 2021


Event Voice: Your Questions Answered by Octopus Investments at Investment Select

Richard Power, Head of Quoted Smaller Companies at Octopus Investments



Can you give a brief overview of your strategy in terms of what you are trying to achieve for investors, your investment process and the make-up of the investment team?

The lead manager of the fund is Richard Power, who has been running the fund since its launch in 2007. Richard is directly assisted by Chris McVey and Dominic Weller in addition to the wider Quoted Companies Team at Octopus which consists of 8 investment professionals. The team manage a range of mandates focused on quoted smaller companies, including two AIM Venture Capital Trusts which ensures a good focus on, and understanding of, the smallest quoted companies. Collectively, the team manage £2.2bn.

We invest in small, relatively early-stage businesses. These micro cap companies tend to be sub-100 million. In general, we're looking for companies that can become relevant in their particular sector on a global scale and have the potential to grow to a multiple of the size they are at the point of investment.

Our philosophy is to become long-term co-owners in businesses that are very progressive and will become increasingly relevant in the world. We won't do what some other micro-cap funds might do, which is sell when companies get to a certain market cap. We'll continue to hold them until we think that they have reached a point where all of the upside is in the share price.

That means we've got a core portfolio of companies that are profitable and on a recognisable growth trajectory. We hope those businesses can double their profits in a three to five-year time horizon. A lot of our holdings have been in the portfolio for ten years and have gone up ten, 15 or 20-fold in that time.

[nico115] 26/3/2021 22:54

Great news Wow strong confidence by the CFO5 March 2021Evgen Pharma plc("Evgen Pharma" or "the Company")Director dealingEvgen Pharma plc (AIM: EVG), a clinical stage drug development company, has been notified that Richard Moulson, Chief Financial Officer of the Company, has purchased 3,787 ordinary shares of 0.25 pence each in the capital of the Company ("Ordinary Shares") at a purchase price of 8 pence per Ordinary Share, as part of the Open Offer in the recent Fundraise. Following this purchase, Richard Moulson holds a total of 45,454 Ordinary Shares, representing approximately 0.02 per cent. of the Company's issued share capital.Enquiries:

[nico115] 26/3/2021 21:42

Haha says AmerettoSo you deramp STX where directors keep buying And ramp evg WHERE DIRECTORS REFUSE TO BUY I THINK EVG WILL BE 2p and STX 100pI hold both but much larger In STX I may DUMP my evg Why should I keep when directors here hold no shares

[nico115] 26/3/2021 21:40

You get a life mate You post hundreds of times a day V sad existence Directors refuse to buy They are on a freebie They laugh at your posts Is they aren't confident why are you ?

[moneymunch] 26/3/2021 21:30

nico's got his coat and gone...:-)

[moneymunch] 26/3/2021 20:52

Lol...get a life you little dipstick...ho ho ho :-)

[nico115] 26/3/2021 20:32

Wonder if Helen will buy Doubt it

[nico115] 26/3/2021 20:32

NO SKIN IN THE GAME DISGRACE MUNCHKIN

[nico115] 26/3/2021 20:31

Bore off The directors are laughing at you I told peter wall to buy Argo at 5p and he did and they are now 230pI told directors to but evg ans they won't Makes me think they know the drugs may not work ? I'm thinking of dumping..something not right Directors won't buy a share after the huge fall to multi year lows

[moneymunch] 26/3/2021 19:02

Lol...move on then mate and find something else you like...Gl :-)

[nico115] 26/3/2021 18:11

Are you paid by evg to ramp ?Do you really think directors have any confidence at all?!I don't !!They refuse to buy shares Just free options Toothless No skin in the game

[bumpa33] 26/3/2021 11:14

I don’t know Rb, been seeing weakness in a number of smaller caps, juniors, AIM stuff etc over the last week to 10 days. Just a theory, crystallising losses, gains for tax purposes...

[riggerbeautz] 26/3/2021 08:48

I’m amazed that still has much of an effect when traders can squirrel away so much in ISA’s/SIPPR17;s as well as so many tax free instruments these days.

[bumpa33] 26/3/2021 07:46

End of tax year rebalancing going on I’m sure across the board, I always forget this time of year is weak ahead of April (6th)

[moneymunch] 26/3/2021 07:39

Near term are fortunes here are dependent on Prof Chalmers preliminary efficacy assessment on SFX-01 for Covid/ARDS, expected Q2, positive data should see significant upside and negative data could see a significant drop , although the share price should recover very quickly as other news from the rest of the pipeline is delivered.

Evgen confirmed 17/2/21 that the Data Safety Monitoring Board would assess safety on the first 60 patients and results would be published early Q2, yet results arrived earlier than stated on 11/3/21 confirming no safety concerns and Evgen confirmed at the same time that the DSBM would then assess the first 100 patients and Prof Chalmers would assess for efficacy, with results expected during Q2, and so it's highly possible that this assessment could already be in progress and results could arrive sooner rather than later, and so obviously i'm hoping Prof Chalmers efficacy results arrive before any other material news from the rest of the pipeline to cover all outcomes. Positive data will be a game changer and truly transformational for all concerned. Gla ;-)

[lovewinshatelosses] 25/3/2021 19:31

Just read that article, Bumpa. From what I have seen in the small cap space in the short time I have been involved in trading and investing outside of the established markets, I would say AIM seems little different to 20 years ago, quite frankly. Not to say that the main markets are a bastion of virtue either, of course!
I guess nobody in the wider world really cares either way though. They do not think it has any impact on their lives, whether true or not.
Lets just hope he and the others that have left or reduced here, have not got it right on this occasion.

[lovewinshatelosses] 25/3/2021 15:57

dutch - I think every raise I have got involved with has gone lower, but it is the simple fear of missing out that tends to pull us in the next time again! Also to reduce the dilutive effect of course, as well.
I remember being particularly frustrated when SBTX raised at 16p - a price I still feel was lower than it needed to be at that point - but at least some decent inside buying took place - and of course now, all is well for those participants. Similarly with many others I am familiar with.
Someone on another board said that holders have short memories. Certainly if/when a company turns a corner and starts to deliver for its holders, this is a fair statement. All will be forgotten here too, if Huw delivers for us, IMO.